Koninklijke Philips (AMS:PHIA) has been assigned a €53.00 ($62.35) target price by equities researchers at UBS Group in a research note issued on Tuesday, Borsen Zeitung reports.
PHIA has been the topic of several other research reports. The Goldman Sachs Group set a €53.00 ($62.35) price target on shares of Koninklijke Philips in a research note on Monday. Kepler Capital Markets set a €44.00 ($51.76) price target on shares of Koninklijke Philips in a research note on Monday, November 8th. Barclays set a €52.00 ($61.18) price target on shares of Koninklijke Philips in a research note on Wednesday, October 27th. JPMorgan Chase & Co. set a €36.40 ($42.82) target price on shares of Koninklijke Philips in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft set a €42.00 ($49.41) target price on shares of Koninklijke Philips in a report on Tuesday, October 19th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of €47.76 ($56.19).
Koninklijke Philips has a 12 month low of €28.92 ($34.02) and a 12 month high of €36.12 ($42.49).
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Featured Article: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.